Axon Enterprise, Inc. (NASDAQ:AXON) Shares Sold by Swedbank AB

Swedbank AB lessened its stake in Axon Enterprise, Inc. (NASDAQ:AXONFree Report) by 13.9% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 114,181 shares of the biotechnology company’s stock after selling 18,422 shares during the period. Swedbank AB owned about 0.15% of Axon Enterprise worth $67,860,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Quent Capital LLC grew its holdings in shares of Axon Enterprise by 1,875.0% in the third quarter. Quent Capital LLC now owns 79 shares of the biotechnology company’s stock valued at $32,000 after purchasing an additional 75 shares in the last quarter. Prestige Wealth Management Group LLC boosted its position in Axon Enterprise by 115.8% in the 3rd quarter. Prestige Wealth Management Group LLC now owns 82 shares of the biotechnology company’s stock valued at $33,000 after buying an additional 44 shares during the period. Brooklyn Investment Group acquired a new position in shares of Axon Enterprise in the third quarter worth $41,000. Planning Capital Management Corp increased its position in shares of Axon Enterprise by 83.3% during the third quarter. Planning Capital Management Corp now owns 121 shares of the biotechnology company’s stock worth $48,000 after acquiring an additional 55 shares during the period. Finally, Friedenthal Financial acquired a new stake in shares of Axon Enterprise in the third quarter valued at $51,000. Hedge funds and other institutional investors own 79.08% of the company’s stock.

Insider Buying and Selling

In related news, insider Jeffrey C. Kunins sold 21,834 shares of the company’s stock in a transaction that occurred on Tuesday, November 12th. The stock was sold at an average price of $593.88, for a total value of $12,966,775.92. Following the sale, the insider now owns 154,394 shares of the company’s stock, valued at approximately $91,691,508.72. This represents a 12.39 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Michael Garnreiter sold 1,000 shares of the stock in a transaction on Monday, December 16th. The shares were sold at an average price of $639.69, for a total value of $639,690.00. Following the sale, the director now owns 24,259 shares in the company, valued at approximately $15,518,239.71. This trade represents a 3.96 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 50,545 shares of company stock worth $30,721,337 in the last quarter. Company insiders own 6.10% of the company’s stock.

Analyst Ratings Changes

A number of brokerages recently issued reports on AXON. JMP Securities lifted their price target on shares of Axon Enterprise from $430.00 to $500.00 and gave the stock a “market outperform” rating in a research note on Thursday, October 31st. Needham & Company LLC lifted their price objective on shares of Axon Enterprise from $525.00 to $600.00 and gave the stock a “buy” rating in a research report on Friday, November 8th. Northland Securities increased their target price on Axon Enterprise from $365.00 to $550.00 and gave the company an “outperform” rating in a report on Monday, November 11th. TD Cowen initiated coverage on Axon Enterprise in a report on Wednesday, January 8th. They issued a “buy” rating and a $700.00 price objective on the stock. Finally, Morgan Stanley upgraded Axon Enterprise from an “equal weight” rating to an “overweight” rating and boosted their target price for the stock from $500.00 to $700.00 in a research note on Tuesday, December 3rd. One analyst has rated the stock with a hold rating and fourteen have assigned a buy rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $524.85.

View Our Latest Stock Report on AXON

Axon Enterprise Price Performance

Shares of NASDAQ AXON opened at $639.97 on Thursday. The company’s fifty day moving average is $618.90 and its two-hundred day moving average is $477.78. The company has a debt-to-equity ratio of 0.32, a quick ratio of 2.63 and a current ratio of 2.96. The firm has a market capitalization of $48.80 billion, a P/E ratio of 165.37, a PEG ratio of 6.09 and a beta of 1.04. Axon Enterprise, Inc. has a one year low of $247.04 and a one year high of $698.67.

Axon Enterprise Profile

(Free Report)

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.

See Also

Institutional Ownership by Quarter for Axon Enterprise (NASDAQ:AXON)

Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.